Family Medicine Doctors in Mansfield, MA Accepting Medicare

5 Family Medicine doctors found. Showing 1 - 5

Stephen Paul Kajencki, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 S Main St, Suite 304, Mansfield, MA 02048 Phone: 508-964-5560    Fax: 508-964-5570

Dr. Amit Johnny Grover, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Copeland Dr, Mansfield, MA 02048 Phone: 508-618-2175

Sonal R. Patel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Copeland Dr, Mansfield, MA 02048 Phone: 508-339-4144    Fax: 508-342-1929

Mark T Bright, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Copeland Dr, Mansfield, MA 02048 Phone: 508-339-4144    Fax: 508-261-9940

Marguerite Garofalo, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 Chauncy St Ste 2, Mansfield, MA 02048 Phone: 508-339-2900    Fax: 508-680-8181

News Archive

Interim study results demonstrate anti-tumor activity of CytRx's INNO-206 in myeloma tumor cells

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced interim study results that showed its doxorubicin prodrug INNO-206 demonstrated statistically significant anti-tumor activity in human myeloma tumor cells growing in immune-deficient mice compared to a control group, while exhibiting significantly less toxicity than doxorubicin even though INNO-206 was administered at much higher doses.

Lung cancer and melanoma funders form first-ever research collaboration

LUNGevity Foundation today announced a partnership with the Lung Cancer Research Foundation and Melanoma Research Alliance to co-fund new innovative research on PD-1 inhibitor treatment options for both non-small cell lung cancer (NSCLC) and metastatic melanoma (MM) patients with brain metastases.

Arsanis closes Series A financing for $10 million

Arsanis, Inc, a recently founded biotechnology company dedicated to the development of anti-infective monoclonal antibody therapeutics, today announced the closing of a Series A financing with a total funding amount of $10 million. Proceeds from the initial financing will be used to advance several programs in the anti-microbial infectious disease area.

Bayer HealthCare to present its clinical trial data at a joint Multidisciplinary Congress

Bayer HealthCare today announced that data from more than 30 clinical trials evaluating three products in the company's oncology portfolio - Nexavar(R) (sorafenib) tablets, regorafenib (BAY 73-4506) and Alpharadin(TM) - will be presented at the joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress, September 20-24, 2009 in Berlin, Germany.

Read more Medical News

› Verified 7 days ago